Meet us at #FDA 2025
Free Hybrid Public Workshop on Pediatric Drug Development Safety and Novel Alternative Methods
Our CEO, Dr. Stephan Schaller, is an invited speaker for a joint CERSi FDA workshop on the topic of “Pediatric Developmental Safety Assessment: Novel Alternative Methods” next February.
His lecture topic is:
“Importance of Using PBPK /QSP for Quantitation in Biological Safety Assessment: Deltametrin Example and Neurotoxicity”, based on our study with Bayer Crop Sciences.
–> Info and Workshop Registration
.
Get in touch now
Contact
ESQlabs GmbH | Am Sportplatz 7 | 26683 Saterland | Germany
Tel. +49 151 / 58559070 | info@esqLABS.com
This site does not use cookies to track your personal information